Akums Drugs and Pharmaceuticals Limited (BOM:544222)
687.05
+2.75 (0.40%)
At close: Jul 14, 2026
BOM:544222 Market Cap
BOM:544222 has a market cap or net worth of 105.17 billion as of July 15, 2026. Its market cap has increased by 28.41% in one year.
Market Cap
105.17B
Enterprise Value
90.46B
Revenue
43.61B
Ranking
n/a
PE Ratio
41.21
Stock Price
687.05
Market Cap Chart
Since August 6, 2024, BOM:544222's market cap has decreased from 125.32B to 105.17B, a decrease of -16.08%. That is a compound annual growth rate of -8.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 105.17B | 51.51% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 236.94B |
| Granules India | 222.40B |
| AstraZeneca Pharma India | 206.78B |
| Caplin Point Laboratories | 198.92B |
| Jubilant Pharmova | 154.25B |
| CORONA Remedies | 125.63B |
| Viyash Scientific | 124.06B |
| Procter & Gamble Health | 113.94B |